Bowel damage assessment in Crohn's disease by magnetic resonance imaging

Current Drug Targets

Volumn 13, Issue 10, 2012, Pages 1300-1307

  Fiorino, Gionata ^a   Peyrin Biroulet, Laurent ^b   Danese, Silvio ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Crohn's disease; Damage; Inflammatory bowel disease; Magnetic resonance imaging; Score

Indexed keywords

ABDOMINAL ABSCESS; ACCURACY; AUTOIMMUNE DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DIARRHEA; ENDOSCOPY; HUMAN; INTESTINAL FIBROSIS; INTESTINE FISTULA; INTESTINE INJURY; INTESTINE OBSTRUCTION; MALNUTRITION; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SCORING SYSTEM; ULTRASOUND;

CROHN DISEASE; HUMANS; INTESTINES; MAGNETIC RESONANCE IMAGING;

EID: 84866564913     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945012802429705     Document Type: Review

References (62)

1. Freeman HJ. Natural history and clinical behavior of Crohn's disease extending beyond two decades. J Clin Gastroenterol 2003; 37(3): 216-9.
2. Szabò H, Fiorino G, Spinelli A, et al. Review article: anti-fibrotic agents for the treatment of Crohn's disease-lessons learnt from other diseases. Aliment Pharmacol Ther 2010; 31(2): 189-201.
3. Van Assche G, Dignass A, Panes J, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis 2010; 4(1): 7-27.
4. Yamamoto T. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol 2005; 11(26): 3971-9.
5. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Con-gresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6(1): 8-15.
6. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49(6): 777-82.
7. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8(4): 244-50.
8. Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 2012; 61(2): 241-7.
9. Molenaar ET, Voskuyl AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans BA. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 2004; 50(1): 36-42
10. Cosnes J, de Parades V, Carbonnel F, et al. Classification of the sequelae of bowel resection for Crohn's disease. Br J Surg 1994; 81(11): 1627-31.
11. Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: metaanalysis of prospective studies. Radiology 2008; 247(1): 64-79.
12. Panes J, Bouzas R, Chaparro M, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther 2011; 34(2): 125-45.
13. Pariente B, Cosnes J, Danese S, et al. Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis 2011; 17(6): 1415-22.
14. Fiorino G, Bonifacio C, Malesci A, Balzarini L, Danese S. MRI in Crohn's disease-current and future clinical applications. Nat Rev Gastroenterol Hepatol 2011; 9(1): 23-31.
15. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999; 26(3): 743-5.
16. Boers M, Felson DT. Clinical measures in rheumatoid arthritis: which are most useful in assessing patients? J Rheumatol 1994; 21(9): 1773-4.
17. Tamai M, Kawakami A, Uetani M, et al. Magnetic resonance imaging (MRI) detection of synovitis and bone lesions of the wrists and finger joints in early-stage rheumatoid arthritis: comparison of the accuracy of plain MRI-based findings and gadoliniumdiethylenetriamine pentaacetic acid-enhanced MRI-based findings. Mod Rheumatol 2011. [Epub ahead of print].
18. Ostergaard M, Hansen M, Stoltenberg M, et al. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 1999; 42(5): 918-29.
19. Foley-Nolan D, Stack JP, Ryan M, et al. Magnetic resonance imaging in the assessment of rheumatoid arthritis--a comparison with plain film radiographs. Br J Rheumatol 1991; 30(2): 101-6.
20. Tamai M, Kawakami A, Iwamoto N, et al. Comparative study of the detection of joint injury in early-stage rheumatoid arthritis by MRI of wrist and finger joints and physical examination. Arthritis Care Res (Hoboken) 2011; 63(3): 436-9.
21. Agarwal SK. Core management principles in rheumatoid arthritis to help guide managed care professionals. J Manag Care Pharm 2011; 17(9 Suppl B): S03-8.
22. Haavardsholm EA, Boyesen P, Ostergaard M, Schildvold A, Kvien TK. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis 2008; 67(6): 794-800.
23. Palosaari K, Vuotila J, Takalo R, et al. Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study. Rheumatology (Oxford) 2006; 45(12): 1542-8.
24. Quinn MA, Conaghan PG, O'Connor PJ, et al. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52(1): 27-35.
25. Voulgari PV, Alamanos Y, Drosos AA. Persistent clinical response of infliximab therapy in patients with refractory rheumatoid arthritis, over a 3-year period. Curr Clin Pharmacol 2006; 1(1): 103-8.
26. Rudwaleit M, Jurik AG, Hermann KG, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/ OMERACT MRI group. Ann Rheum Dis 2009; 68(10): 1520-7.
27. Jee WH, McCauley TR, Lee SH, Kim SH, Im SA, Ha KY. Sacroiliitis in patients with ankylosing spondylitis: association of MR findings with disease activity. Magn Reson Imaging 2004; 22(2): 245-50.
28. Madsen KB, Schiottz-Christensen B, Jurik AG. Prognostic significance of magnetic resonance imaging changes of the sacroiliac joints in spondyloarthritis--a followup study. J Rheumatol 2010; 37(8): 1718-27.
29. Mau W, Zeidler H, Mau R, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol 1988; 15(7): 1109-14.
30. Braun J, Landewe R, Hermann KG, et al. Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, doubleblind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 2006; 54(5): 1646-52.
31. Schett G, Coates LC, Ash ZR, Finzel S, Conaghan PG. Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future. Arthritis Res Ther 2011; 13 (Suppl 1): S4.
32. Schnitzler F, Fidder H, Ferrante M, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 2009; 15(9): 1295-301.
33. Rimola J, Rodriguez S, Garcia-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 2009; 58(8): 1113-20.
34. Rimola J, Ordas I, Rodriguez S, et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011; 17(8): 1759-68.
35. Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease. Inflamm Bowel Dis 2011; 17(5): 1073-80.
36. Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in smallbowel Crohn's disease. AJR Am J Roentgenol 2009; 193(1): 113-21.
37. Peyrin-Biroulet L, Loftus EV, Jr., Colombel JF, Sandborn WJ. Early Crohn disease: a proposed definition for use in diseasemodification trials. Gut 2010; 59(2): 141-7.
38. Magnano G, Granata C, Barabino A, et al. Polyethylene glycol and contrast-enhanced MRI of Crohn's disease in children: preliminary experience. Pediatr Radiol 2003; 33(6): 385-91.
39. van Gemert-Horsthuis K, Florie J, Hommes DW, et al. Feasibility of evaluating Crohn's disease activity at 3.0 Tesla. J Magn Reson Imaging 2006; 24(2): 340-8.
40. Florie J, Horsthuis K, Hommes DW, et al. Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease. Clin Gastroenterol Hepatol 2005; 3(12): 1221-8.
41. Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2-versus T1-weighted gadoliniumenhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 2006; 238(2): 517-30.
42. Negaard A, Paulsen V, Sandvik L, et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis. Eur Radiol 2007; 17(9): 2294-301.
43. Tillack C, Seiderer J, Brand S, et al. Correlation of magnetic resonance enteroclysis (MRE) and wireless capsule endoscopy (CE) in the diagnosis of small bowel lesions in Crohn's disease. Inflamm Bowel Dis 2008; 14(9): 1219-28.
44. Martinez MJ, Ripolles T, Paredes JM, Blanc E, Marti-Bonmati L. Assessment of the extension and the inflammatory activity in Crohn's disease: comparison of ultrasound and MRI. Abdom Imaging 2009; 34(2): 141-8.
45. Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology 2009; 251(3): 751-61.
46. Pilleul F, Godefroy C, Yzebe-Beziat D, Dugougeat-Pilleul F, Lachaux A, Valette PJ. Magnetic resonance imaging in Crohn's disease. Gastroenterol Clin Biol 2005; 29(8-9): 803-8.
47. Potthast S, Rieber A, Von Tirpitz C, Wruk D, Adler G, Brambs HJ. Ultrasound and magnetic resonance imaging in Crohn's disease: a comparison. Eur Radiol 2002; 2(6): 1416-22.
48. Gasche C, Moser G, Turetschek K, Schober E, Moeschl P, Oberhuber G. Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease. Gut 1999; 44(1): 112-7.
49. Best WR, Becktel JM, Singleton JW, Kern F, Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70(3): 439-44.
50. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980; 1(8167): 514.
51. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989; 30(7): 983-9.
52. Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004; 60(4): 505-12.
53. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99(4): 956-63.
54. Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 2011; 61: 241-7.
55. Pariente B, Peyrin-Biroulet L, Cohen L, Zagdanski AM, Colombel JF. Gastroenterology review and perspective: the role of crosssectional imaging in evaluating bowel damage in Crohn disease. AJR Am J Roentgenol 2011; 197(1): 42-9.
56. Coremans G, Rutgeerts P, Geboes K, Van den Oord J, Ponette E, Vantrappen G. The value of ileoscopy with biopsy in the diagnosis of intestinal Crohn's disease. Gastrointest Endosc 1984; 30(3): 167-72.
57. Witte AM, Veenendaal RA, Van Hogezand RA, Verspaget HW, Lamers CB. Crohn's disease of the upper gastrointestinal tract: the value of endoscopic examination. Scand J Gastroenterol 1998; Suppl (225): 100-5.
58. Fireman Z, Mahajna E, Broide E, et al. Diagnosing small bowel Crohn's disease with wireless capsule endoscopy. Gut 2003; 52(3): 390-2.
59. Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med 2007; 357(22): 2277-84.
60. Peloquin JM, Pardi DS, Sandborn WJ, et al. Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2008; 103(8): 2015-22.
61. Van Assche G, Vanbeckevoort D, Bielen D, et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 2003; 98(2): 332-9.
62. Fornasa F, Benassuti C, Benazzato L. Role of Magnetic Resonance Enterography in Differentiating between Fibrotic and Active Inflammatory Small Bowel Stenosis in Patients with Crohn's Disease. J Clin Imaging Sci 2011; 1: 35.